ODTX
Odyssey Therapeutics, Inc.Closed17.24−1.02 −5.59%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 17.24 0.00%
Open
18.15
Prev close
18.26
Day range
17.1818.40
52-week range
15.1029.05
Volume
258.82K0.98×
Mkt cap
828.53M
P/E ttm
—
Fwd P/E
-4.15
EPS ttm
-7.55
Div yield
0.00%
Earnings
Aug 4, 2026
From 52w high
−40.65%
ODTX shareholders
ODTX Ownership
13F / N-PORT filings via Yahoo
Institutions
83.1%
88.6% of the float
Insiders
6.2%
officers and directors
Institutional holders
66
filing positions
Top 10 institutions
51.7%
10 adding · 0 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| FMR, LLC | 10.78% | 5.18M | $89.29M | +100.0% | Jun 30, 2026 |
| SR One Capital Management, LP | 7.90% | 3.79M | $65.42M | +100.0% | Jun 30, 2026 |
| TPG GP A, LLC | 7.68% | 3.69M | $63.62M | +100.0% | Jun 30, 2026 |
| Lightspeed Management Company, L.L.C. | 7.51% | 3.61M | $62.21M | +100.0% | Jun 30, 2026 |
| Orbimed Advisors LLC. | 6.24% | 3.00M | $51.74M | +100.0% | Jun 30, 2026 |
| Sanofi | 4.14% | 1.99M | $34.34M | +100.0% | Jun 30, 2026 |
| Deerfield Management Company, L.P | 2.18% | 1.05M | $18.04M | +100.0% | Jun 30, 2026 |
| Sands Capital Alternatives, LLC | 1.82% | 875.00K | $15.08M | +100.0% | Jun 30, 2026 |
| HHLR Advisors, LTD | 1.73% | 831.66K | $14.34M | +100.0% | Jun 30, 2026 |
| General Catalyst Group Management, LLC | 1.69% | 810.27K | $13.97M | +100.0% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.30% | 1.10M | $19.04M | +6.9% | Aug 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.11% | 531.10K | $9.16M | +100.0% | Jun 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.71% | 340.70K | $5.87M | +0.3% | Aug 31, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 0.64% | 308.86K | $5.32M | +7.0% | Aug 31, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 0.55% | 266.60K | $4.60M | +7.0% | Aug 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.38% | 182.55K | $3.15M | +100.0% | Jun 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.37% | 179.66K | $3.10M | +100.0% | Jun 30, 2026 |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 0.21% | 99.83K | $1.72M | +100.0% | Jul 31, 2026 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.16% | 76.36K | $1.32M | −0.5% | Aug 31, 2026 |
| abrdn Healthcare Investors | 0.12% | 57.75K | $995.61K | +100.0% | Jun 30, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).